Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Posterior subthalamic area deep brain stimulation for treatment of tremor and dystonia in Wilson's disease.

Low HL, Alexander SK, Misbahuddin A, Gillett GT.

Brain Stimul. 2019 May 21. pii: S1935-861X(19)30221-9. doi: 10.1016/j.brs.2019.05.014. [Epub ahead of print] No abstract available.

PMID:
31138489
2.

Natural History of Vanishing White Matter.

Hamilton EMC, van der Lei HDW, Vermeulen G, Gerver JAM, Lourenço CM, Naidu S, Mierzewska H, Gemke RJBJ, de Vet HCW, Uitdehaag BMJ, Lissenberg-Witte BI; VWM Research Group, van der Knaap MS.

Ann Neurol. 2018 Aug;84(2):274-288. doi: 10.1002/ana.25287. Epub 2018 Sep 6.

3.

INTEREST IN CD2, a global patient-centred study of long-term cervical dystonia treatment with botulinum toxin.

Misra VP, Colosimo C, Charles D, Chung TM, Maisonobe P, Om S; INTEREST IN CD2 study group.

J Neurol. 2018 Feb;265(2):402-409. doi: 10.1007/s00415-017-8698-2. Epub 2017 Dec 21.

4.

Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry.

Antonini A, Poewe W, Chaudhuri KR, Jech R, Pickut B, Pirtošek Z, Szasz J, Valldeoriola F, Winkler C, Bergmann L, Yegin A, Onuk K, Barch D, Odin P; GLORIA study co-investigators.

Parkinsonism Relat Disord. 2017 Dec;45:13-20. doi: 10.1016/j.parkreldis.2017.09.018. Epub 2017 Sep 22.

5.

Toscana virus encephalitis following a holiday in Sicily.

Osborne JC, Khatamzas E, Misbahuddin A, Hart R, Sivaramakrishnan A, Breen DP.

Pract Neurol. 2016 Apr;16(2):139-41. doi: 10.1136/practneurol-2015-001265. Epub 2015 Dec 8.

PMID:
26647398
6.

Comment on the Article by Ledermann et al. Entitled 'Effects of Cerebellothalamic Tractotomy on Cognitive and Emotional Functioning in Essential Tremor: A Preliminary Study in 5 Essential Tremor Patients'.

Fuller CJ, Misbahuddin A, Prezerakos GK, Haliasos N, Low HL.

Stereotact Funct Neurosurg. 2015;93(6):378-9. doi: 10.1159/000440728. Epub 2015 Nov 18. No abstract available.

7.

The Impact of Deep Brain Stimulation on Sleep and Olfactory Function in Parkinson's Disease.

Breen DP, Low HL, Misbahuddin A.

Open Neurol J. 2015 Sep 30;9:70-2. doi: 10.2174/1874205X01509010070. eCollection 2015.

8.

Tracking Parkinson's: Study Design and Baseline Patient Data.

Malek N, Swallow DM, Grosset KA, Lawton MA, Marrinan SL, Lehn AC, Bresner C, Bajaj N, Barker RA, Ben-Shlomo Y, Burn DJ, Foltynie T, Hardy J, Morris HR, Williams NM, Wood N, Grosset DG; PRoBaND.

J Parkinsons Dis. 2015;5(4):947-59. doi: 10.3233/JPD-150662.

9.

Reversible cerebral vasoconstriction syndrome as a cause of thunderclap headache: a retrospective case series study.

Papathanasiou A, Zouvelou V, Breen DP, Phillips TJ, Misbahuddin A, Chawda S, de Silva R.

Am J Emerg Med. 2015 Jun;33(6):859.e3-6. doi: 10.1016/j.ajem.2014.12.026. Epub 2014 Dec 19.

PMID:
25583268
10.

Vanishing white matter disease presenting as opsoclonus myoclonus syndrome in childhood--a case report and review of the literature.

Klingelhoefer L, Misbahuddin A, Jawad T, Mellers J, Jarosz J, Weeks R, Ray Chaudhuri K.

Pediatr Neurol. 2014 Jul;51(1):157-64. doi: 10.1016/j.pediatrneurol.2014.03.008. Epub 2014 Mar 15. Review.

PMID:
24938145
11.

Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial.

PD Med Collaborative Group, Gray R, Ives N, Rick C, Patel S, Gray A, Jenkinson C, McIntosh E, Wheatley K, Williams A, Clarke CE.

Lancet. 2014 Sep 27;384(9949):1196-205. doi: 10.1016/S0140-6736(14)60683-8. Epub 2014 Jun 11. Erratum in: Lancet. 2014 Sep 27;384(9949):1186.

PMID:
24928805
12.

Systematic review and UK-based study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson's disease.

Kilarski LL, Pearson JP, Newsway V, Majounie E, Knipe MD, Misbahuddin A, Chinnery PF, Burn DJ, Clarke CE, Marion MH, Lewthwaite AJ, Nicholl DJ, Wood NW, Morrison KE, Williams-Gray CH, Evans JR, Sawcer SJ, Barker RA, Wickremaratchi MM, Ben-Shlomo Y, Williams NM, Morris HR.

Mov Disord. 2012 Oct;27(12):1522-9. doi: 10.1002/mds.25132. Epub 2012 Sep 6. Review.

PMID:
22956510
13.

Do patients wish to 'listen in' when doctors dictate letters to colleagues?

de Silva R, Misbahuddin A, Mikhail S, Grayson K.

JRSM Short Rep. 2010 Nov 2;1(6):47. doi: 10.1258/shorts.2010.010049.

14.

Myoclonus-dystonia syndrome with severe depression is caused by an exon-skipping mutation in the epsilon-sarcoglycan gene.

Misbahuddin A, Placzek M, Lennox G, Taanman JW, Warner TT.

Mov Disord. 2007 Jun 15;22(8):1173-5.

PMID:
17230465
15.

Mutant torsinA, which causes early-onset primary torsion dystonia, is redistributed to membranous structures enriched in vesicular monoamine transporter in cultured human SH-SY5Y cells.

Misbahuddin A, Placzek MR, Taanman JW, Gschmeissner S, Schiavo G, Cooper JM, Warner TT.

Mov Disord. 2005 Apr;20(4):432-40.

PMID:
15593317
16.

Focal dystonia is associated with a polymorphism of the dopamine D5 receptor gene.

Misbahuddin A, Placzek MR, Warner TT.

Adv Neurol. 2004;94:143-6. No abstract available.

PMID:
14509667
17.

Analysis of the epsilon-sarcoglycan gene in familial and sporadic myoclonus-dystonia: evidence for genetic heterogeneity.

Valente EM, Misbahuddin A, Brancati F, Placzek MR, Garavaglia B, Salvi S, Nemeth A, Shaw-Smith C, Nardocci N, Bentivoglio AR, Berardelli A, Eleopra R, Dallapiccola B, Warner TT.

Mov Disord. 2003 Sep;18(9):1047-51.

PMID:
14502674
18.

A polymorphism in the dopamine receptor DRD5 is associated with blepharospasm.

Misbahuddin A, Placzek MR, Chaudhuri KR, Wood NW, Bhatia KP, Warner TT.

Neurology. 2002 Jan 8;58(1):124-6.

PMID:
11781417
19.

Dystonia: an update on genetics and treatment.

Misbahuddin A, Warner TT.

Curr Opin Neurol. 2001 Aug;14(4):471-5. Review.

PMID:
11470963
20.

Cervical dystonia is associated with a polymorphism in the dopamine (D5) receptor gene.

Placzek MR, Misbahuddin A, Chaudhuri KR, Wood NW, Bhatia KP, Warner TT.

J Neurol Neurosurg Psychiatry. 2001 Aug;71(2):262-4.

Supplemental Content

Loading ...
Support Center